Alpha-1-proteinase inhibitor drug data and news

Alpha-1-proteinase inhibitor drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Alpha-1-proteinase inhibitor
Brand Names/Synonyms Alpha-1-antitrypsin precursor;Alpha-1 protease inhibitor;Alpha-1- antiproteinase; Aralast (Baxter); Prolastin (Talecris Biotherapeutics ¨C formerly Bayer)
Indication For treatment of panacinar emphysema
Sponsored links
Description Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.
Pharmacology Prevents excessive accumulation of active neutrophil elastase and consequent proteolysis of elastin tissues in alveolar lung structures. This prevents the development of emphysema.
Mechanism Of Action Alpha-1 proteinase inhibitor is a serine protease inhibitor (Serpin). It primarily inhibits the action of the serine protease called elastase (also plasmin and thrombin). The reactive center loop (RCL) of alpha-1 proteinase inhibitor extends out from the body of the protein and directs binding to the target protease. The protease cleaves the serpin at the reactive site, establishing a covalent linkage between the carboxyl group of the serpin reactive site and the serine hydroxyl of the protease. The resulting inactive serpin-protease complex is highly stable.
Alpha-1-proteinase inhibitor News
(When available)
[an error occurred while processing this directive]
Dosage Forms POWDER FOR SOLUTION
Drug_Category Enzyme replacement; enzymes (44:00.00)
Absorption Not Available
Interactions Not Available
Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name Alpha-1-proteinase inhibitor
Chemical Formula C2001H3130N514O601S10
Molecular Weight 44324.5
Smiles String Not Available
Melting Point 59 oC at pH 7.8 (Tew D.J., Bottomley, S.P. J. Mol. Biol. 313:1161-1169 (2001)).
Water Solubility Not Available
State Transparent, slightly viscous, aqueous liquid
LogP/Hphobicity -0.302
Isoelectric Point 5.37
Biotransformation Not Available
Half Life Not Available
Protein Binding [%] Not Available
RxList Link RXlist
Sponsored links
Drug Reference http://www.rxlist.com/cgi/generic3/zemaira.htm
Drug Type Approved Drug
Accession No BIOD00002
CAS Registry Number 9041-92-3
KEGG Compound ID Not Available
PubChem ID Not Available
PharmGKB ID PA448329
SwissProt ID A1AT_HUMAN (P01009)
GenBank ID K01396
Drug ID Number [DIN] 2204606

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org